StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Restructuring-related asset impairments by Quarter

Restructuring-related asset impairments ($M) ($M)

QuarterlyAnnual

Pfizer Restructuring-related asset impairments: $54M in Q2 2026, up 22.7% from a year earlier.

Latest, Q2 2026
54
Period ended Jun 28, 2026
Change on a year earlier
+22.7%
44 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
33
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Note 3 — Restructuring Charges & Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRestructuring-related asset impairments ($M) ($M)Year on yearSource
Q2 2026Jun 28, 202654+22.7%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 29, 202628-83.8%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 202521-91.8%Form 10-K (filed 2026-02-26) ↗
Q3 2025Sep 28, 20251110.0%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 29, 202544+7.3%Form 10-Q (filed 2026-08-04) ↗
Q1 2025Mar 30, 2025173+592.0%Form 10-Q (filed 2026-05-05) ↗
Q4 2024Dec 31, 2024255+40.1%Form 10-K (filed 2026-02-26) ↗
Q3 2024Sep 29, 2024111+177.5%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 202441+173.3%Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 202425-350.0%Form 10-Q (filed 2025-05-05) ↗
Q4 2023Dec 31, 2023182+2,175.0%Form 10-K (filed 2026-02-26) ↗
Q3 2023Oct 1, 202340+135.3%Form 10-Q (filed 2024-11-04) ↗
Q2 2023Jul 2, 202315-25.0%Form 10-Q (filed 2024-08-05) ↗
Q1 2023Apr 2, 2023-10-225.0%Form 10-Q (filed 2024-05-08) ↗
Q4 2022Dec 31, 20228-82.6%Form 10-K (filed 2025-02-27) ↗
Q3 2022Oct 2, 202217+70.0%Form 10-Q (filed 2023-11-08) ↗

Cite this data

StockData. (2026). Pfizer Restructuring-related asset impairments ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/restruct-chg-imp

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.